By reporting on the psychological impact of BRCA1/2 tumour genetic testing for ovarian cancer in Ontario, we hope to inform the successful implementation of tumour genetic testing at other institutions and for additional tumour types. The gene discussed is BRCA1; the disease is ovarian carcinoma.